Dose–response relationship - Wikipedia
Definitions of dose limiting toxicity. | Download Table
Designing Dose-Finding Phase I Clinical Trials: Top 10 Questions That Should Be Discussed With Your Statistician | JCO Precision Oncology
On Biostatistics and Clinical Trials: Dose Limiting Toxicity (DLT) and Common Toxicity Criteria (CTC) / Common Terminology Criteria for Adverse Events (CTCAE)
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
DLT - Dose Limiting Toxicity - determined by phase 1 studies
PPT - Novel Targeted Drugs and Their Introduction to the Clinic PowerPoint Presentation - ID:6720294
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study - ScienceDirect
Innovative design for a phase 1 trial with intra-patient dose escalation: The Crotoxin study. - Abstract - Europe PMC
Adaptive Design Methods in Clinical Trials - ppt download
Maximum tolerated doses and dose-limiting toxic effects by schedule. | Download Table
Predictive Toxicology Approaches for Small Molecule Oncology Drugs
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
definition of dose-limiting toxicity. | Download Table
Phase I trials - memoinOncology
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma | Haematologica
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature. | Semantic Scholar
On Biostatistics and Clinical Trials: Maximum Tolerable Dose (MTD) and Dose-Limiting Toxicities (DLTs)
Towards new methods for the determination of dose limiting toxicities and the assessment of the recommended dose for further studies of molecularly targeted agents – Dose-Limiting Toxicity and Toxicity Assessment Recommendation Group
